Curesign Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Seed
- Investors
-
2
Curesign General Information
Description
Developer of medical devices designed to optimize oncology treatments. The company's technology and devices are based on integrating sensors with advanced signal processing and big data tools, enabling clinical teams to tailor patient-specific treatment for each cancer patient.
Contact Information
Website
www.curesign.comCorporate Office
- Tel Aviv
- Israel
Corporate Office
- Tel Aviv
- Israel
Curesign Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 01-Feb-2020 | Completed | Pre-Clinical Trials |
Curesign Signals
Curesign Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Nacre Capital | Venture Capital | Minority | ||
| Peregrine Ventures | Venture Capital | Minority |
Curesign FAQs
-
When was Curesign founded?
Curesign was founded in 2019.
-
Where is Curesign headquartered?
Curesign is headquartered in Tel Aviv, Israel.
-
What is the size of Curesign?
Curesign has 4 total employees.
-
What industry is Curesign in?
Curesign’s primary industry is Therapeutic Devices.
-
Is Curesign a private or public company?
Curesign is a Private company.
-
What is Curesign’s current revenue?
The current revenue for Curesign is .
-
Who are Curesign’s investors?
Nacre Capital and Peregrine Ventures have invested in Curesign.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process